interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate, and who makes it?

Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate2 dosage-form groups in the Orange Book
0generic makers listed
  1. Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 2 groups have a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Extended Release, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Dyanavel Xr 10, Dyanavel Xr 15, Dyanavel Xr 20 and Dyanavel Xr 5. No generic is listed as marketed.

2020202520302035204001brand 2021data datePatent 8337890 listed to expire 15 March 2027Patent 8747902 listed to expire 15 March 2027Patent 9675704 listed to expire 15 March 2027Patent 11590081 listed to expire 24 September 2038Patent 12734132 listed to expire 24 September 2038Patent 12458592 listed to expire 11 February 2040
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 15 March 2027Patent 8337890 drug product
  • 15 March 2027Patent 8747902 drug product
  • 15 March 2027Patent 9675704 drug product
  • 24 September 2038Patent 11590081 drug product
  • 24 September 2038Patent 12734132
  • 11 February 2040Patent 12458592

Suspension, Extended Release, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Dyanavel Xr. No generic is listed as marketed.

20152020202520302035204001brand 2015data datePatent 8597684 listed to expire 15 March 2027Patent 10086087 listed to expire 15 March 2027Patent 8747902 listed to expire 15 March 2027Patent 8883217 listed to expire 15 March 2027Patent 9675703 listed to expire 15 March 2027Patent 8062667 listed to expire 29 March 2029Patent 11590228 listed to expire 7 September 2036
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 15 March 2027Patent 8597684 drug product
  • 15 March 2027Patent 10086087 drug product
  • 15 March 2027Patent 8747902 drug product
  • 15 March 2027Patent 8883217 drug product
  • 15 March 2027Patent 9675703 drug product
  • 29 March 2029Patent 8062667 drug product
  • 7 September 2036Patent 11590228 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.